Rachel Colman, M.D
Pain Medicine (Psychiatry & Neurology) Physician · Cheshire, CT
Rachel Colman, M.D is a pain medicine (psychiatry & neurology) physician with a practice address in Cheshire, Connecticut, and NPI 1396979951, issued on May 12, 2009. Check the license (Connecticut 068597, as entered in NPPES) on the Connecticut Medical Examining Board; the Medicare figures below come from public CMS files.
- Name
- Rachel Colman
- Credential
- M.D
- Primary taxonomy
- Pain Medicine (Psychiatry & Neurology) Physician 2084P2900X
- License number
- 068597 CT
Self-reported in NPPES; status is on the state search - Practice location
- 280 S Main St # 103, Cheshire, CT 06410
- Phone
- (860) 696-2925
- Enumerated
- May 12, 2009
- Record last updated
- Jun 26, 2024
- Medicare enrollment
- Enrolled (PECOS I20211007000111); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest pain medicine (psychiatry & neurology) physician records → All 10 in Connecticut → Look up another NPI →
Verify Rachel Colman in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersConnecticut Medical Examining Board
Search for license 068597Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
5% more Medicare Part D claims than the average pain medicine (psychiatry & neurology) physician in 2024
1,436 Medicare Part D claims for 165 beneficiaries, against an average of 1,374 among the 130 providers of this specialty who prescribed in Part D. Brand-name drugs were 37% of claims.
Most prescribed
- Ubrelvy141 claims
- Tizanidine Hcl107 claims
- Gabapentin84 claims
- Sumatriptan Succinate83 claims
- Aimovig Autoinjector80 claims
- Nurtec Odt67 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $918.79
61 payments; by number, the most common kind was food and beverage; the largest payer was Abbvie Inc. The 96 providers of this specialty with any payment received $1,718.51 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Hartford Healthcare Medical Group Specialists PLLCCheshire, CT
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Rachel Colman among 10 pain medicine (psychiatry & neurology) physician records in Connecticut
Rachel Colman, M.D is one of 10 pain medicine (psychiatry & neurology) physician records with a practice address in Connecticut. 60% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2009, is newer than 40% of them.
- NPI issued2009 · 40% of these records are older, 50% newer
- In a Medicare fileYes · 60% of these records are
- In the CMS Doctors and Clinicians fileYes · 60% of these records are
- Record last updated2024 · 50% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 2084P2900X and a Connecticut practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Pain Medicine (Psychiatry & Neurology) Physician providers in Connecticut
There are 10 pain medicine (psychiatry & neurology) physician records in Connecticut.
All 10 in Connecticut → Every provider in Cheshire → Pain Medicine (Psychiatry & Neurology) Physician nationwide →
The 8 pain medicine (psychiatry & neurology) physician records with the nearest ZIP codes
- Aakash Bhargava, MDNorwich, CT 063601689170466
- Katherine Podraza, MD PHDMystic, CT 063551457731986
- Igor Turok, M.D.Wallingford, CT 064921972575801
- Susan Israel, M.D.Woodbridge, CT 065251538604566
- Christopher Ttofi, M.D.Newington, CT 061111598814279
- Brian Grosberg, MDWest Hartford, CT 061071437234739
- Sandhya Mehla, MBBSWest Hartford, CT 061071215356399
- James Brodey, MDFarmington, CT 060321235278458
Common questions
What is Rachel Colman, M.D's NPI number?
Rachel Colman, M.D's National Provider Identifier (NPI) is 1396979951, issued on May 12, 2009. An NPI identifies a provider in billing; it is not a license.
Where is Rachel Colman, M.D located?
The NPPES record lists a practice address at 280 S Main St # 103, Cheshire, CT, 06410. Phone: (860) 696-2925. Providers update this record themselves, so call before visiting.
How can I verify Rachel Colman, M.D's license?
NPPES lists Connecticut license number 068597, as entered by the provider. Search the Connecticut Medical Examining Board at https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Rachel Colman, M.D prescribe under Medicare Part D?
In 2024, Rachel Colman, M.D had 1,436 Medicare Part D claims for 165 beneficiaries; the average among pain medicine (psychiatry & neurology) physician prescribers was 1,374. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.